1. New Pathways in Syphilis Vaccine Development.
- Author
-
Liu A, Giacani L, Hawley KL, Cameron CE, Seña AC, Konda KA, Radolf JD, and Klausner JD
- Subjects
- Humans, Antigens, Bacterial immunology, Syphilis prevention & control, Syphilis immunology, Treponema pallidum immunology, Vaccine Development, Bacterial Vaccines immunology, Bacterial Vaccines administration & dosage
- Abstract
Abstract: The New Pathways in Syphilis Vaccine Development meeting was held before the start of the STI & HIV 2023 World Congress as a pre-meeting symposium to highlight recent advances in the development of an effective syphilis vaccine and discuss the challenges still faced by investigators. Internationally renowned public health officials, clinical investigators, and basic researchers from academia, government, and community-based organizations met on July 24, 2023, in Chicago, Illinois. Four speakers discussed key research findings in syphilis vaccine development, which included antigen selection, identification of epitopes associated with protective immunity, and delivery platforms, with great emphasis on development of chimeric antigens. Significant progress was also shown on the elucidation of Treponema pallidum genomes from virtually all continents to assess the diversity in vaccine candidates of the syphilis spirochete., Competing Interests: Conflict of Interest and Sources of Funding: Studies discussed in this review were supported by grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (R01 AI155217, R01 AI139265, and R21 AI173988 to J.D.K., U19 AI144133 to L.G. and C.C., and U19 AI144177 to J.D.R.). Dr. Klausner is an advisor for Direct Diagnostics, LLC., (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association.)
- Published
- 2024
- Full Text
- View/download PDF